The possible relationship between consumption of trans fatty acids (TFAs) and risk of insulin resistance or development of diabetes mellitus type II has been considered by a number of human and animal studies over the past decade. This review evaluates the evidence, and concludes that there is limited evidence for a weak association at high TFA intakes, but very little convincing evidence that habitual exposure as part of a standard western diet has a significant contribution to risk of diabetes or insulin resistance. The possibility of increased risk for individuals with particular genotypes (such as the FABP2 Thr54 allele) is of interest, but further work would be required to provide sufficient evidence of any association.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Lipids in Health and Disease Open Access 27 April 2020
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Almeida JC, Gross JL, Canani LH, Zelmanovitz T, Perassolo MS, Azevedo MJ (2010). The Ala54Thr polymorphism of the FABP2 gene influences the postprandial fatty acids in patients with type 2 diabetes. J Clin Endocrinol Metab 95: 3909–3917.
Alstrup KK, Brock B, Hermansen K (2004). Long-term exposure of INS-1 cells to cis and trans fatty acids influences insulin release and fatty acid oxidation differentially. Metabolism 53, 1158–1165.
Alstrup KK, Gregersen S, Jensen HM, Thomsen JL, Kjeld H (1999). Differential effects of cis and trans fatty acids on insulin release from isolated mouse islets. Metabolism 48, 22–29.
Bernal CA, Rovira J, Colandré ME, Cussó R, Cadefau JA (2006). Effects of dietary cis and trans unsaturated and saturated fatty acids on the glucose metabolites and enzymes of rats. Br J Nutr 95, 947–954.
Christiansen E, Schnider S, Palmvig B, Tauber-Lassen E, Pedersen O (1997). Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 20, 881–887.
Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE (1992). Diet and risk of clinical diabetes in women. Am J Clin Nutr 55, 1018–1023.
Cromer KD, Jenkins TC, Thies EJ (1995). Replacing cis octadecenoic acid with trans isomers in media containing rat adipocytes stimulates lipolysis and inhibits glucose utilization. J Nutr 125, 2394–2399.
Dorfman SE, Laurent D, Gounarides JS, Li X, Mullarkey TL, Rocheford EC et al. (2009). Metabolic implications of dietary trans-fatty acids. Obesity.
Esmaillzadeh A, Azadbakht L (2008). Consumption of hydrogenated versus nonhydrogenated vegetable oils and risk of insulin resistance and the metabolic syndrome among Iranian adult women. Diabetes Care 31, 223–226.
European Food Safety Authority (2004). Opinion of the scientific panel on the dietetic products, nutrition and allergies on a request from the commission related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids. EFSA J 81, 1–49.
Food Standards Australia New Zealand (2009). Intakes of trans fatty acids in New Zealand and Australia. Internet: http://www.foodstandards.gov.au/scienceandeducation/publications/transfattyacidsrepor4560.cfm.
Halton TL, Willett WC, Liu S, Manson JE, Stampfer MJ, Hu FB (2006). Potato and french fry consumption and risk of type 2 diabetes in women. Am J Clin Nutr 83, 284–290.
Health Canada (2006). Transforming the food supply, report of the trans fat task force. internet: http://www.hc-sc.gc.ca/fn-an/nutrition/gras-trans-fats/tf-ge/tf-gt_rep-rap-eng.php.
Hodge AM, English DR, O′Dea K, Sinclair AJ, Makrides M, Gibson RA et al. (2007). Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 86, 189–197.
Hu FB (2001). Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44, 805–817.
Huang Z, Wang B, Pace RD, Yoon S (2009). Trans fat intake lowers total cholesterol and high-density lipoprotein cholesterol levels without changing insulin sensitivity index in Wistar rats. Nutr Res 29, 206–212.
Ibrahim A, Natarajan S, Ghafoorunissa R (2005). Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats. Metabolism 54, 240–246.
Kavanagh K, Jones KL, Sawyer J, Kelley K, Carr JJ, Wagner JD et al. (2007). Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity 15, 1675–1684.
Koppe SWP, Elias M, Moseley RH, Green RM (2009). Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. Am J Physiol Gastrointest Liver Physiol 297, G378–G384.
Larque E, Gil-Campos M, Ramirez-Tortosa MC, Linde J, Canete R, Gil A (2006). Postprandial response of trans fatty acids in prepubertal obese children. Int J Obes 30, 1488–1493.
Lefevre M, Lovejoy JC, Smith SR, DeLany JP, Champagne C, Most MM et al. (2005). Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metabolism 54, 1652–1658.
Lemaitre RN, King IB, Patterson RE, Psaty BM, Kestin M, Heckbert SR (1998). Assessment of trans-fatty acid intake with a food frequency questionnaire and validation with adipose tissue levels of trans-fatty acids. Am J Epidemiol 148, 1085–1093.
Lichtenstein A, Erkkilä A, Lamarche B, Schwab U, Jalbert S, Ausman L (2003). Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 171, 97–107.
Louheranta AM, Turpeinen AK, Vidgren HM, Schwab US, Uusitupa MIJ (1999). A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 48, 870–875.
Lovejoy JC, Champagne CM, Smith SR, DeLany JP, Bray GA, Lefevre M et al. (2001). Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. Metabolism 50, 86–92.
Lovejoy JC, Smith SR, Champagne CM, Most MM, Lefevre M, DeLany JP et al (2002). Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 25, 1283–1288.
Meyer KA, Kushi LH, Jacobs Jr DR, Folsom AR (2001). Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 24, 1528–1535.
Mozaffarian D, Clarke R (2009). Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 63, S22–S33.
SACN (2002). A framework for evaluation of evidence that relates food and nutrients to health. Internet: http://www.sacn.gov.uk/pdfs/sacn_02_02a.pdf.
SACN (2007). Update on Trans Fatty Acids and Health. Position Statement by the Scientific Advisory Committee on Nutrition (SACN). HMSO: London.
Salmerón J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB et al. (2001). Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73, 1019–1026.
Saravanan N, Haseeb A, Ehtesham NZ, Ghafoorunissa R (2005a). Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur J Endocrinol 153, 159–165.
Saravanan N, Ibrahim A, Ghafoorunissa R (2005b). Dietary trans fatty acids alter diaphragm phospholipid fatty acid composition, tryacylglycerol content and glucose transport in rats. Br J Nutr 93, 829–833.
Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD et al. (1997). The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100, 398–403.
Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, Tuomilehto J et al. (2004). Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr 7, 147–165.
Sundram K, Karupaiah T, Hayes KC (2007). Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans. Nutr Metabol 4, 3.
Tardy A-L, Giraudet C, Rousset P, Rigaudiere J-P, Laillet B, Chalancon S et al. (2008). Effects of trans MUFA from dairy and industrial sources on muscle mitochondrial function and insulin sensitivity. J Lipid Res 49, 1445–1455.
Tardy A-L, Lambert-Porcheron S, Malpuech-Brugere C, Giraudet C, Rigaudiere J-P, Laillet B et al. (2009). Dairy and industrial sources of trans fat do not impair peripheral insulin sensitivity in overweight women. Am J Clin Nutr 90, 88–94.
Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM (2006). Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr 83, 237–243.
van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB (2002). Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25, 417–424.
van de Vijver LPL, Kardinaal AFM, Couet C, Aro A, Kafatos A, Steingrimsdottir L et al. (2000). Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur J Clin Nutr 54, 126–135.
Vega-Lopez S, Ausman LM, Jalbert SM, Erkkila AT, Lichtenstein AH (2006). Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am J Clin Nutr 84, 54–62.
Wang Y, Jacome-Sosa MM, Ruth MR, Goruk SD, Reaney MJ, Glimm DR et al (2009). Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats. J Nutr 139, 2049–2054.
Wang Y, Lu J, Ruth MR, Goruk SD, Reaney MJ, Glimm DR et al. (2008). Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR:LA-cp rats. J Nutr 138, 2117–2122.
Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes. Diabetes Care 27, 1047–1053.
Xu J, Eilat-Adar S, Loria CM, Howard BV, Fabsitz RR, Begum M et al. (2007). Macronutrient intake and glycemic control in a population-based sample of American Indians with diabetes: the Strong Heart Study. Am J Clin Nutr 86, 480–487.
We thank the Food Standards Agency (UK) for providing funding. Funding for Update on trans fatty acids and health provided by Food Standards Agency (UK).
The authors declare no conflict of interest.
About this article
Cite this article
Thompson, A., Minihane, AM. & Williams, C. Trans fatty acids, insulin resistance and diabetes. Eur J Clin Nutr 65, 553–564 (2011). https://doi.org/10.1038/ejcn.2010.240
This article is cited by
Lipids in Health and Disease (2020)
Saturated and monounsaturated fatty acid status is associated with bone strength estimated by calcaneal ultrasonography in Inuit women from Nunavik (Canada): A cross-sectional study
The journal of nutrition, health & aging (2014)
European Journal of Clinical Nutrition (2012)